About: Ultrasmall superparamagnetic iron oxides (USPIOs): a future alternative magnetic resonance (MR) contrast agent for patients at risk for nephrogenic systemic fibrosis (NSF)?

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Ultrasmall superparamagnetic iron oxides (USPIOs): a future alternative magnetic resonance (MR) contrast agent for patients at risk for nephrogenic systemic fibrosis (NSF)? Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 08 October 2008

Attributes	Values
rdf:type	Item
description	videnskabelig artikel (da) article científic (ca) articolo scientifico (it) artigo científico (pt) bilimsel makale (tr) vedecký článok (sk) vetenskaplig artikel (sv) vědecký článek (cs) wetenschappelijk artikel (nl) wissenschaftlicher Artikel (de) научни чланак (sr) article scientifique (fr) artículu científicu espublizáu en 2008 (ast) наукова стаття, опублікована в жовтні 2008 (uk) scientific article published on 08 October 2008 (en) مقالة علمية نشرت في 08 أكتوبر 2008 (ar)
publication date	wds:Q37098753-A75501BE-87D7-477A-8B07-8EA9F054C004
publication date	2008-10-08 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q37098753-C454C295-7F00-40B2-B2D3-D889500FABC4
language of work or name	English
exact match	wds:Q37098753-3835AA77-FF32-450E-A469-12F5C3FAC809
exact match	https://scigraph.springernature.com/pub.10.1038/ki.2008.496
cites work	wds:Q37098753-036E8BD4-98D3-4A37-872C-6FBDA8401FEC wds:Q37098753-1A094686-6F7F-4230-8AE2-664FEE203B8A wds:Q37098753-26B8982B-70F2-460F-94EC-98E5B9847109 wds:Q37098753-3189F6FF-7499-4C67-B690-D1338C5D6BAA wds:Q37098753-356B4366-83E4-44C2-B3C3-E41661230423 wds:Q37098753-3E505D89-A618-4AA0-83BE-97A097629483 wds:Q37098753-4A2B4FC2-E709-41DB-B511-64030011EF43 wds:Q37098753-64307963-FE31-4F79-BB7C-CA9D5578523C wds:Q37098753-6CEE8C79-CC66-4F6F-9368-B8C78BAC935E wds:Q37098753-76927D86-F10C-42DD-98CA-91A6E58B05E8 wds:Q37098753-7A5FE3B3-0FFE-48F2-A753-28F4B8FA52F2 wds:Q37098753-8C47D655-BB23-41A2-A0F5-DF905AA82F05 wds:Q37098753-9B4A77C1-C08B-4CB4-912D-683C7F3CE2C9 wds:Q37098753-AE29568E-948D-409E-9C93-FC27907BC9D7 wds:Q37098753-B2C56415-B065-4D34-90E8-84A454610D68 wds:Q37098753-C10551DE-356E-49F1-9528-6B19F56D5657 wds:Q37098753-C66656B2-EA1C-4DB1-B435-A639D4645629 wds:Q37098753-C73694DF-43B7-4EFA-B0FF-9C39CD9C45A7 wds:Q37098753-D28EE5F3-78F1-4651-B13C-25F62D23DE5B wds:Q37098753-D542CFEE-DEB5-4B5B-B3FE-CEF7F8C826D1 wds:Q37098753-E2BE1437-2D43-4A83-83DD-513F52A9B3C8 wds:Q37098753-EC490903-7752-4E32-81B3-FA8511C27AB5 wds:Q37098753-FA29A608-4506-4526-9AA8-554A58C4BBDB wds:Q37098753-FE3380E8-8AFB-4C25-B269-63A95C59296D
cites work	Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and Applications Macrophage imaging in central nervous system and in carotid atherosclerotic plaque using ultrasmall superparamagnetic iron oxide in magnetic resonance imaging. Capacity of human monocytes to phagocytose approved iron oxide MR contrast agents in vitro The potential of ferumoxytol nanoparticle magnetic resonance imaging, perfusion, and angiography in central nervous system malignancy: a pilot study. An exploratory study of ferumoxtran-10 nanoparticles as a blood-brain barrier imaging agent targeting phagocytic cells in CNS inflammatory lesions. In vivo leukocyte labeling with intravenous ferumoxides/protamine sulfate complex and in vitro characterization for cellular magnetic resonance imaging. Pluriformity of inflammation in multiple sclerosis shown by ultra-small iron oxide particle enhancement Physical and chemical properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil Imaging of iron oxide nanoparticles by MR and light microscopy in patients with malignant brain tumours. First-pass and equilibrium-MRA of the aortoiliac region with a superparamagnetic iron oxide blood pool MR contrast agent (SH U 555 C): results of a human pilot study. First-pass contrast-enhanced magnetic resonance angiography in humans using ferumoxytol, a novel ultrasmall superparamagnetic iron oxide (USPIO)-based blood pool agent. Pharmacokinetic study of ferumoxytol: a new iron replacement therapy in normal subjects and hemodialysis patients Blood pool MR angiography of aortic stent-graft endoleak. New insights into nephrogenic systemic fibrosis Nephrogenic systemic fibrosis, gadolinium, and iron mobilization Gadolinium and nephrogenic systemic fibrosis. Tissue distribution and kinetics of gadolinium and nephrogenic systemic fibrosis Single-dose contrast agent for intraoperative MR imaging of intrinsic brain tumors by using ferumoxtran-10. Comparison of two superparamagnetic viral-sized iron oxide particles ferumoxides and ferumoxtran-10 with a gadolinium chelate in imaging intracranial tumors Delivery of virus-sized iron oxide particles to rodent CNS neurons Assessment of brain tumor angiogenesis inhibitors using perfusion magnetic resonance imaging: quality and analysis results of a phase I trial. MR angiography with blood pool contrast agents Imaging in the time of NFD/NSF: do we have to change our routines concerning renal insufficiency? Nephrogenic systemic fibrosis: a sufficient reason to avoid gadolinium-based contrast in all patients with renal impairment?
author name string	wds:Q37098753-5DD9DFC0-37B8-4FDC-982D-CDF1E9603071 wds:Q37098753-66478727-0E42-4996-9D43-E05A9807AAFE wds:Q37098753-8DCA7562-EE0A-4EDC-B8BD-D41A091E01F6 wds:Q37098753-8EADB58E-1972-4249-9AA3-231D56C8848E wds:Q37098753-9119A609-9E5D-486F-8286-9FD9A24A58D6 wds:Q37098753-E7469FBB-B9DE-4C43-81DC-ACC34D13BE87
author name string	Bronwyn E Hamilton Csanad G Varallyay Paula M Jacobs Suzanne G Watnick William R Rooney Robert D Edelman
rdfs:label	Ultrasmall superparamagnetic iron oxides (nl) Ultrasmall superparamagnetic iron oxides (USPIOs): a future alternative magnetic resonance (MR) contrast agent for patients at risk for nephrogenic systemic fibrosis (NSF)? (en) Ultrasmall superparamagnetic iron oxides (USPIOs): a future alternative magnetic resonance (MR) contrast agent for patients at risk for nephrogenic systemic fibrosis (NSF)? (ast)
skos:prefLabel	Ultrasmall superparamagnetic iron oxides (nl) Ultrasmall superparamagnetic iron oxides (USPIOs): a future alternative magnetic resonance (MR) contrast agent for patients at risk for nephrogenic systemic fibrosis (NSF)? (en) Ultrasmall superparamagnetic iron oxides (USPIOs): a future alternative magnetic resonance (MR) contrast agent for patients at risk for nephrogenic systemic fibrosis (NSF)? (ast)
name	Ultrasmall superparamagnetic iron oxides (nl) Ultrasmall superparamagnetic iron oxides (USPIOs): a future alternative magnetic resonance (MR) contrast agent for patients at risk for nephrogenic systemic fibrosis (NSF)? (en) Ultrasmall superparamagnetic iron oxides (USPIOs): a future alternative magnetic resonance (MR) contrast agent for patients at risk for nephrogenic systemic fibrosis (NSF)? (ast)
author	wds:Q37098753-EB732CA2-48C5-4C88-BCC0-88400E7417FD
author	Edward Neuwelt
title	wds:Q37098753-16156F5F-3A4A-4AF2-9D0D-856D08ECDE42
title	Ultrasmall superparamagnetic iron oxides (USPIOs): a future alternative magnetic resonance (MR) contrast agent for patients at risk for nephrogenic systemic fibrosis (NSF)? (en)
page(s)	wds:Q37098753-114B5A26-FF0B-417D-9F0B-E7EE04F0F489
page(s)	465-474
instance of	wds:Q37098753-F12A65D9-9637-420C-A9C6-275604F18535 wds:Q37098753-edf1ed6a-81d4-4ca0-8440-03df2c07775b

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 195 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software